Path ID: DB00508_MESH_D011618_2
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:D014273 | Triflupromazine | Drug |
| UniProt:P14416 | D(2) dopamine receptor | Protein |
| MESH:D004298 | Dopamine | ChemicalSubstance |
| HP:0000738 | Hallucinations | PhenotypicFeature |
| HP:0000746 | Delusions | PhenotypicFeature |
| MESH:D011618 | Psychotic Disorders | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Triflupromazine | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| D(2) Dopamine Receptor | POSITIVELY CORRELATED WITH | Dopamine |
| Dopamine | CONTRIBUTES TO | Hallucinations |
| Dopamine | CONTRIBUTES TO | Delusions |
| Hallucinations | MANIFESTATION OF | Psychotic Disorders |
| Delusions | MANIFESTATION OF | Psychotic Disorders |
Reference: